Biomimetic and Natural Exosomes in Drug Delivery: A Critical Review.
- 1Translational Research with iPS Cells Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre, imas12, Avda. de Córdoba s/n, 28041 Madrid, Spain.
- 2Department of Chemical Engineering and Materials, University Complutense of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.
Abstract
Exosomes are biological nanoparticles (30-150 nm) secreted by most eukaryotic cells. They are composed of a lipid bilayer membrane and an inner compartment that stores various cellular components. In recent years, research on exosomes has grown exponentially due to their biocompatibility, low immunogenicity and cytotoxicity, and their permeability to biological barriers. Among the most promising applications of exosomes are their diagnostic and therapeutic potential, the latter being especially relevant due to their ability to act as a vehicle for drugs. Before exosomes can be applied clinically, it is necessary to optimize the isolation of these nanoparticles from various sources, as well as to carry out their physical and biochemical characterization. Furthermore, their ability to encapsulate molecules with therapeutic effects within them must be perfected. To this end, analytical methods are a key tool for developing each of these steps, and it is essential to understand their principles, strengths, and challenges. In addition, it is necessary to overcome limitations such as the availability of safe sources, the scalability of production, the standardization of isolation, purification, and encapsulation, the inherent heterogeneity of exosomes themselves, the prolongation of in vivo lifespan, and the long-term preservation of these nanoparticles. An alternative is the synthesis of exosome-like nanoparticles, which is less complex but more prone to high production and tailored structure and composition. This review addresses the latest advances in drug delivery focused on exosomes and exosome biomimetic nanoparticles, comparing their advantages and drawbacks from a practical perspective.
Related
- Engineered Natural Membrane Vesicle Exosomes as a Torin2 Delivery Platform for Targeted Therapy of Anaplastic Thyroid Carcinoma.
- Engineering exosomes-mediated RNA delivery regulates bone homeostasis and alleviates osteoporosis.
- Ultrasound-Triggered piRNA Delivery Using Biomimetic Phase-Changeable Nanoparticles for Theranostics of Myocardial Infarction.
- Stem cell-derived exosomes in the therapy of renal diseases: a comprehensive review.
- Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review
BibTeX
@article{roblesanda2026biomimetic,
title = {{Biomimetic and Natural Exosomes in Drug Delivery: A Critical Review.}},
author = {Natalia Robles-Anda and Raquel González-Jabardo and Miguel Ladero and M Esther Gallardo},
journal = {Biomimetics (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/biomimetics11100747},
url = {https://europepmc.org/article/MED/42930299},
note = {CC BY},
}
RIS
TY - JOUR
TI - Biomimetic and Natural Exosomes in Drug Delivery: A Critical Review.
AU - Natalia Robles-Anda
AU - Raquel González-Jabardo
AU - Miguel Ladero
AU - M Esther Gallardo
PY - 2026
DA - 2026/10/16
JO - Biomimetics (Basel, Switzerland)
DO - 10.3390/biomimetics11100747
UR - https://europepmc.org/article/MED/42930299
AB - Exosomes are biological nanoparticles (30-150 nm) secreted by most eukaryotic cells. They are composed of a lipid bilayer membrane and an inner compartment that stores various cellular components. In recent years, research on exosomes has grown exponentially due to their biocompatibility, low immunogenicity and cytotoxicity, and their permeability to biological barriers. Among the most promising applications of exosomes are their diagnostic and therapeutic potential, the latter being especially relevant due to their ability to act as a vehicle for drugs. Before exosomes can be applied clinically, it is necessary to optimize the isolation of these nanoparticles from various sources, as well as to carry out their physical and biochemical characterization. Furthermore, their ability to encapsulate molecules with therapeutic effects within them must be perfected. To this end, analytical methods are a key tool for developing each of these steps, and it is essential to understand their principles, strengths, and challenges. In addition, it is necessary to overcome limitations such as the availability of safe sources, the scalability of production, the standardization of isolation, purification, and encapsulation, the inherent heterogeneity of exosomes themselves, the prolongation of in vivo lifespan, and the long-term preservation of these nanoparticles. An alternative is the synthesis of exosome-like nanoparticles, which is less complex but more prone to high production and tailored structure and composition. This review addresses the latest advances in drug delivery focused on exosomes and exosome biomimetic nanoparticles, comparing their advantages and drawbacks from a practical perspective.
SN - 2313-7673
ER -